MetaCap

GoodRx Earnings

NASDAQ: GDRXTechnologyEDP ServicesUSD

3.43+0.07 (+2.08%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Next earnings date

Tue, Nov 3, 2026

Fiscal period

Sep/2026

EPS estimate

$0.04

GoodRx earnings summary

GoodRx is scheduled to report Sep/2026 earnings on Nov 3, 2026, with analysts expecting EPS of $0.04. In its most recent report on Aug 5, 2026 (Q2 2026), GDRX posted EPS of $0.02. Revenue for the quarter was $200.4 million.

Quarterly EPS is down 50.0% from the same quarter a year earlier. Across the last 16 reports, GDRX shares moved an average of 9.7% (in either direction) in the first trading session after results, rising 5 times and falling 11 times.

Summary generated from market data by MetaCap's automated system. Methodology

GDRX earnings history

GoodRx reported EPS versus estimates
Report dateEPS est.EPS actualSurprisePrice reaction
Aug 5, 2026—$0.02—+1.4%
May 6, 2026—$0.00—-16.8%
Feb 25, 2026—$0.02—+21.9%
Nov 4, 2025—$0.00—-4.5%
Aug 6, 2025—$0.04—+7.5%
May 7, 2025—$0.03—-8.3%
Feb 27, 2025—$0.01—-7.4%
Nov 7, 2024—$0.01—-15.1%
Aug 8, 2024—$0.02—-0.6%
May 9, 2024—$0.00—+13.3%
Feb 29, 2024—$-0.06—-11.5%
Nov 9, 2023—$-0.09—+9.2%
Aug 9, 2023—$0.14—-15.0%
May 10, 2023—$-0.01—-0.4%
Mar 1, 2023—$-0.01—-2.7%
Nov 9, 2022—$-0.10—-19.1%

Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.

Related